Serious errors in new volume on Agent Orange and dioxin.
Hardell
L
L
Department of Oncology, University Hospital, Umeå, Sweden.
D015085:2,4,5-Trichlorophenoxyacetic Acid / Q000009:adverse effects*; D015084:2,4-Dichlorophenoxyacetic Acid / Q000009:adverse effects*; D000075182:Agent Orange; D004147:Dioxins / Q000009:adverse effects*; D004812:Epidemiologic Methods; D006801:Humans; D000072317:Polychlorinated Dibenzodioxins / Q000009:adverse effects*; D011361:Professional Competence
D004147:Dioxins; D000072317:Polychlorinated Dibenzodioxins; D015084:2,4-Dichlorophenoxyacetic Acid; D000075182:Agent Orange; D015085:2,4,5-Trichlorophenoxyacetic Acid